Drugs Information: Ramucirumab
Basic Information
|
||
| ID | DDInter1566 | |
| Drug Type | biotech | |
| Molecular Formula | C6374H9864N1692O1996S46 | |
| Molecular Weight | - | |
| Description | Ramucirumab is an antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply. | |
| ATC Classification | L01XC21 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ramucirumab
| Severity level | ID | Name | Mechanism | Detail |
|---|